Role of Endogenous Endothelin in Chronic Heart Failure
- 16 September 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 96 (6), 1976-1982
- https://doi.org/10.1161/01.cir.96.6.1976
Abstract
Background Plasma levels of the vasoconstrictor peptide endothelin (ET) are increased in chronic heart failure (CHF), and ET levels are a major predictor of mortality in this disease. Thus, ET may ...Keywords
This publication has 15 references indexed in Scilit:
- Increased Survival After Long-Term Treatment With Mibefradil, a Selective T-Channel Calcium Antagonist, in Heart FailureJournal of the American College of Cardiology, 1997
- Inhibition of myocardial endothelin pathway improves long-term survival in heart failureNature, 1996
- Clearance of Circulating Endothelin-1 by ETB Receptors in RatsBiochemical and Biophysical Research Communications, 1994
- Radioimmunological Determination of Endothelin Peptides in Human Plasma: A Methodological ApproachEndothelium, 1994
- Effects of endothelins on collagen turnover in cardiac fibroblastsCardiovascular Research, 1993
- Plasma endothelin concentrations in humans with end-stage heart failure and after heart transplantationJournal of the American College of Cardiology, 1992
- The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivoBiochemical and Biophysical Research Communications, 1992
- Endothelin-1 stimulation of noradrenaline and adrenaline release from adrenal chromaffin cellsBiochemical Pharmacology, 1991
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril.Circulation, 1985